Merck to Pay $650 Million In Medicaid Settlement
86670
Merck agreed yesterday to pay more than $650 million to settle charges that it routinely overbilled the government for its most popular medicines, the arthritis drug Vioxx and the cholesterol drug Zocor, cheating Medicaid out of millions of dollars in discounts over eight years.
139110
Washington Insurance Commissioner Mike Kreidler this week joined officials of 43 other states in signing an estimated $120 million settlement with one of the nation&#39;s largest disability insurers.
29655
GlaxoSmithKline Plc will pay a net $3.1   billion to settle an ongoing tax dispute with the U.S.   government, which was to go to trial next year, Europe's   biggest drugmaker said on Monday.
265877
FRANKFURT/ZURICH  - German drugmaker Merck KGaA   MRCG.DE unveiled a surprise 16.6-billion-Swiss franc ($13.3   billion) deal to buy Swiss biotech firm Serono on Thursday,   creating a new force in European pharmaceuticals.
157720
WASHINGTON, Feb. 14  â Merck & Company agreed Wednesday to pay $2.3 billion to resolve several tax disputes, the Internal Revenue Service said.
715189
Boston Scientific said Thursday that three of its subsidiaries had agreed to pay $16.75 million and extend the warranty on some of its heart devices as part of a settlement with state attorneys general.
534842
The deal will settle claims that Merck overcharged Medicaid programs, and resolve charges over marketing.
344354
TAP Pharmaceutical Products has agreed to pay $150 million to consumers and private insurers to settle claims they overpaid for its drug Lupron because the company artificially inflated the price.
675729
The deal will settle claims that Merck overcharged Medicaid programs for four drugs, including Vioxx and Zocor, and resolve allegations of improper marketing to doctors.
685313
Boston Scientific Corp. will pay $16.75 million to settle state investigations into flawed heart defibrillators sold by Guidant Corp. , whose substantial legal liability Boston Scientific inherited when it bought the firm last year for $27 billion.
64992
Medarex Inc., a Princeton, NJ, biotechnology company, could receive up to $510 million under a global collaboration deal it signed with New York-based Pfizer Inc.
563915
Merck & Co Inc  said on Thursday the New Jersey Supreme Court has reversed a lower court ruling that granted nationwide class-action status to insurers seeking reimbursement for past spending on Vioxx, the drugmaker's withdrawn arthritis treatment.
102179
The drug company will settle claims it overcharged government health programs and improperly enticed doctors to prescribe its drugs.
179385
Merck & Co. Inc.  will pay $2.9 billion to settle three tax disputes with the U.S. Internal Revenue Service, the drugmaker said on Wednesday, but another $1.76 billion dispute with Canadian tax authorities remains unresolved.
300177
Merck & Co Inc.  said on Wednesday it agreed to settle tax disputes with the U.S. Internal Revenue Service at a net cash cost of about $2.3 billion.
524676
HealthSouth Corp. (HLSH.PK: Quote, Profile, Research) , an operator of health care facilities, said on Thursday it agreed to pay $325 million to settle US Department of Justice charges that it improperly billed Medicare.
600651
Merck, the beleaguered US pharmaceuticals group, could be forced to pay out as much as $18bn (Â£9.7bn) over 10 years as a result of lawsuits linked to Vioxx, its controversial arthritis drug.